About 7 results found for searched term "A-779" (0.057 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M3722 | Temsirolimus | mTOR |
| CCI-779; WAY-130779 | ||
| Temsirolimus (WAY-130779, CCI-779) is a specific mTOR inhibitor with IC50 of 1.76 μM. | ||
| M6464 | AR-R 17779 hydrochloride | Others |
| AR-R 17779 hydrochloride is a α7-selective agonist. | ||
| M9091 | A-779 | Angiotensin Receptor |
| A779 | ||
| A-779 is a specific antagonist of G-protein coupled receptor (Mas receptor). | ||
| M9135 | TAK-779 | CCR |
| Takeda 779; TAK779 Chloride | ||
| TAK-779 is a potent and selective nonpeptide antagonist of CCR5, with a Ki of 1.1 nM for CCR5. | ||
| M21193 | SAR247799 | S1P Receptor |
| S1P1 agonist 3 | ||
| The S1P1 agonist SAR247799 is a biased agonist of the S1P1 sphingosine receptor, preferentially activating G protein signaling over the β-arrestin and internalization pathways. | ||
| M25037 | Cevostamab | Others |
| BFCR 4350A; RG 6160; RO 7187797 | ||
| Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells. | ||
| M25401 | ACT-777991 | CXCR |
| ACT-777991 is a highly potent, insurmountable, and selective CXCR3 antagonist that showed dose-dependent efficacy and target engagement in a mouse model of acute lung inflammation. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
